Dibenzyl amine compounds and derivatives

Details for Australian Patent Application No. 2007226261 (hide)

Owner Pfizer Products Inc.

Inventors Zeng, Dongxiang; Lefker, Bruce Allen; Chang, George; Garigipati, Ravi Shanker; Perry, David Austen

Agent Shelston IP

Pub. Number AU-B-2007226261

PCT Pub. Number WO2007/105050

Priority 60/780,993 10.03.06 US; 11/619,277 03.01.07 US

Filing date 26 February 2007

Wipo publication date 20 September 2007

Acceptance publication date 16 August 2012

International Classifications

C07D 257/06 Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

A61K 31/165 - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/27

A61K 31/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 3/06 Drugs for disorders of the metabolism

A61P 9/10 Drugs for disorders of the cardiovascular system

C07C 233/18 Carboxylic acid amides

C07C 271/16 Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07C 275/24 Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/105050 Priority application(s): WO2007/105050

16 August 2012 Application Accepted

  Published as AU-B-2007226261

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007226271-Flat process of drug coating for stents

2007226260-Dibenzyl amine derivatives as CETP inhibitors